Maravai LifeSciences (NASDAQ: MRVI) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $51.4 million versus the consensus estimate of $48.68 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.